Profession Notes

This past March, the nonprofit Arnold and Mabel Beckman Foundation presented grants to 30 young researchers as part of its Beckman Young Investigators (BYI) awards and its Beckman Scholars program for undergraduates. Now in its tenth year, the BYI program has thus far awarded over $30 million to 160 young researchers in the chemical and life sciences. This year, 16 investigators were given $240,000 over three years. The focus of recipients' research projects range from the study of carbohydrate

Written byEugene Russo
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share
This past March, the nonprofit Arnold and Mabel Beckman Foundation presented grants to 30 young researchers as part of its Beckman Young Investigators (BYI) awards and its Beckman Scholars program for undergraduates. Now in its tenth year, the BYI program has thus far awarded over $30 million to 160 young researchers in the chemical and life sciences. This year, 16 investigators were given $240,000 over three years. The focus of recipients' research projects range from the study of carbohydrate structure and function in the brain, to the study inorganic chemistry of marine adhesives, to the development of a cell-free system for mitotic checkpoint control. As part of the Beckman Scholars program, 76 undergraduates at 14 institutions will each receive a $12,500 scholarship for two, 10-week summers of full-time research and $5,000 for 10 hours per week of research during the intervening academic year. Recipients' research activities center around chemistry, biochemistry, and/or the biological and medical sciences. See www.beckman-foudation.com/programs.html for a complete list of award recipients in both programs.

--Eugene Russo

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies